share_log

Intelligent Bio Solutions | S-3: Registration statement for specified transactions by certain issuers

SEC announcement ·  Mar 4 17:32
Summary by Moomoo AI
Intelligent Bio Solutions Inc. has filed a Form S-3 with the Securities and Exchange Commission (SEC) on March 4, 2024, to register shares for potential future sale. This registration statement pertains to the resale of up to 636,367 shares of common stock, which may be issued upon the exercise of certain Series G Warrants and Placement Agent Warrants. The Series G Warrants were issued to certain selling stockholders in exchange for their exercise of existing Series E Warrants, and the Placement Agent Warrants were issued to Ladenburg Thalmann & Co. Inc., the placement agent for the issuance of the Inducement Warrants. The company will not receive any proceeds from the sale of shares by the selling stockholders but will receive the exercise price if...Show More
Intelligent Bio Solutions Inc. has filed a Form S-3 with the Securities and Exchange Commission (SEC) on March 4, 2024, to register shares for potential future sale. This registration statement pertains to the resale of up to 636,367 shares of common stock, which may be issued upon the exercise of certain Series G Warrants and Placement Agent Warrants. The Series G Warrants were issued to certain selling stockholders in exchange for their exercise of existing Series E Warrants, and the Placement Agent Warrants were issued to Ladenburg Thalmann & Co. Inc., the placement agent for the issuance of the Inducement Warrants. The company will not receive any proceeds from the sale of shares by the selling stockholders but will receive the exercise price if the warrants are exercised for cash. The registration allows the selling stockholders to sell their shares from time to time in the public market, through private transactions, or otherwise, at prevailing market prices or at negotiated prices. Intelligent Bio Solutions Inc. has agreed to keep the prospectus effective until all registered shares are sold or the offering is otherwise completed. The company has also entered into indemnification agreements with its directors and officers, and its bylaws provide for indemnification to the fullest extent permitted by Delaware law.

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Doc 5

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more